Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 237

1.

Renal Drug Transporters and Drug Interactions.

Ivanyuk A, Livio F, Biollaz J, Buclin T.

Clin Pharmacokinet. 2017 Feb 16. doi: 10.1007/s40262-017-0506-8. [Epub ahead of print] Review.

PMID:
28210973
2.

Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT).

Voumard R, Van Neyghem N, Cochet C, Gardiol C, Decosterd L, Buclin T, de Valliere S.

J Antimicrob Chemother. 2017 Feb 3. doi: 10.1093/jac/dkw582. [Epub ahead of print] No abstract available.

PMID:
28158637
3.

Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter.

Dao K, Chtioui H, Lu Y, Peer CJ, Figg WD, Pruijm M, Buclin T, Kissling S.

Am J Kidney Dis. 2017 Jan 4. pii: S0272-6386(16)30637-0. doi: 10.1053/j.ajkd.2016.10.026. [Epub ahead of print] No abstract available.

PMID:
28063733
4.

Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure.

Dao K, Lu Y, Peer CJ, Figg WD, Stadelmann R, Burnier M, Buclin T, Kissling S.

Cancer Chemother Pharmacol. 2017 Jan;79(1):215-218. doi: 10.1007/s00280-016-3219-z.

PMID:
27988790
5.

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.

Aouri M, Barcelo C, Guidi M, Rotger M, Cavassini M, Hizrel C, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study..

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e00899-16. doi: 10.1128/AAC.00899-16.

PMID:
27799217
6.

Biases affecting injected doses of an experimental drug during clinical trials.

Perrottet N, Brunner-Ferber F, Grouzmann E, Spertini F, Biollaz J, Buclin T, Widmer N.

Trials. 2016 Jul 16;17(1):321. doi: 10.1186/s13063-016-1463-5.

7.

Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants.

Fuchs A, Zimmermann L, Bickle Graz M, Cherpillod J, Tolsa JF, Buclin T, Giannoni E.

PLoS One. 2016 Jul 8;11(7):e0158806. doi: 10.1371/journal.pone.0158806.

8.

Pregnancy outcome following maternal exposure to pregabalin may call for concern.

Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen LE, Bernard N, Vial T, Yates LM, Pistelli A, Ellfolk M, Eleftheriou G, de Vries LC, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T.

Neurology. 2016 Jun 14;86(24):2251-7. doi: 10.1212/WNL.0000000000002767.

PMID:
27194385
9.

Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.

Barceló C, Gaspar F, Aouri M, Panchaud A, Rotger M, Guidi M, Cavassini M, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study..

J Antimicrob Chemother. 2016 Jul;71(7):1933-42. doi: 10.1093/jac/dkw050.

PMID:
27029846
10.

[Pharmacovigilance update].

Dao K, Chtioui H, Rothuizen LE, Diezi L, Prod'hom S, Winterfeld U, Buclin T, Livio F.

Rev Med Suisse. 2016 Jan 13;12(500):75-9. French.

PMID:
26946710
11.

Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study.

Fuchs A, Rotzinger A, Cavassini M, Bugnon O, Buclin T, Schneider MP, Csajka C.

Ther Drug Monit. 2016 Aug;38(4):506-15. doi: 10.1097/FTD.0000000000000297.

PMID:
26937748
12.

Multigenerational effects of the anticancer drug tamoxifen and its metabolite 4-hydroxy-tamoxifen on Daphnia pulex.

Borgatta M, Waridel P, Decosterd LA, Buclin T, Chèvre N.

Sci Total Environ. 2016 Mar 1;545-546:21-9. doi: 10.1016/j.scitotenv.2015.11.155.

PMID:
26745289
13.

In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.

Aouri M, Barcelo C, Ternon B, Cavassini M, Anagnostopoulos A, Yerly S, Hugues H, Vernazza P, Günthard HF, Buclin T, Telenti A, Rotger M, Decosterd LA; Swiss HIV Cohort Study..

Drug Metab Dispos. 2016 Jan;44(1):151-61. doi: 10.1124/dmd.115.065839.

14.

Pharmacokinetics in hepatic impairment: Mind the protein binding.

Chtioui H, Buclin T.

J Hepatol. 2015 Dec;63(6):1539-40. doi: 10.1016/j.jhep.2015.07.042. No abstract available.

PMID:
26343957
15.

Therapeutic drug monitoring of targeted anticancer therapy.

Decosterd LA, Widmer N, Zaman K, Cardoso E, Buclin T, Csajka C.

Biomark Med. 2015;9(9):887-93. doi: 10.2217/bmm.15.78. Review.

PMID:
26333311
16.

Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.

Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H, Te Winkel B, Clementi M, Pistelli A, Maňáková E, Eleftheriou G, Merlob P, Kaplan YC, Buclin T, Rothuizen LE.

J Clin Psychopharmacol. 2015 Jun;35(3):250-9. doi: 10.1097/JCP.0000000000000309.

PMID:
25830592
17.

The anticancer drug metabolites endoxifen and 4-hydroxy-tamoxifen induce toxic effects on Daphnia pulex in a two-generation study.

Borgatta M, Decosterd LA, Waridel P, Buclin T, Chèvre N.

Sci Total Environ. 2015 Jul 1;520:232-40. doi: 10.1016/j.scitotenv.2015.03.040.

PMID:
25817760
18.

Label-free detection of tobramycin in serum by transmission-localized surface plasmon resonance.

Cappi G, Spiga FM, Moncada Y, Ferretti A, Beyeler M, Bianchessi M, Decosterd L, Buclin T, Guiducci C.

Anal Chem. 2015 May 19;87(10):5278-85. doi: 10.1021/acs.analchem.5b00389.

PMID:
25811093
19.

[Pharmacovigilance update].

Fogarasi Szabo N, Diezi L, Delenclos L, Renard D, Chtioui H, Rothuizen LE, Buclin T, Livio F.

Rev Med Suisse. 2015 Jan 14;11(456-457):124-8. French.

PMID:
25799668
20.

Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: relevance to the diagnosis of neuroblastoma.

Franscini LC, Vazquez-Montes M, Buclin T, Perera R, Dunand M, Grouzmann E, Beck-Popovic M.

Pediatr Blood Cancer. 2015 Apr;62(4):587-93. doi: 10.1002/pbc.25385.

PMID:
25597761
Items per page

Supplemental Content

Loading ...
Support Center